Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.

Details

Language :

English

ISSN :

13464280

Volume :

64

Issue :

2

Database :

Complementary Index

Journal :

Journal of Clinical & Experimental Hematopathology

Publication Type :

Academic Journal

Accession number :

180096773

Full Text :

https://doi.org/10.3960/jslrt.24009